HNP is performing an informal benchmark on Radiation Protection limitations that are put on individuals that have received radionuclide medical treatments. HNP has in an admin procedure "Notifying Radiation Protection of the following: As soon as practical, but prior to, any medical administration of radiopharmaceuticals or radioactive implants." We also have a procedure for monitoring individuals during Medical Radionuclide Procedures after we know they have received a medical radionuclide.
1. Do you place any restrictions on individuals with radionuclide medical treatments such as Technetium-99 or Thallium-201 from entering Protected Area and/or RCA? 2. Do you remove an individual's TLD? 3. If allowed in Protected Area, do you restrict their work area locations or proximity to other personnel? 4. If allowed in Protected Area, what dose rate is allowed? 5. How do you handle individuals that get radioactive iodine? 6. Are limitations, restrictions etc. written as guidelines, policy or procedure? 7. If you have guidelines, policies or procedures will you share? Michael Seabock Lead Radiation Control Specialist - ALARA Harris Nuclear Plant 919.362.2808 * [email protected]
<<inline: image001.gif>>
